Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
暂无分享,去创建一个
E. Miller | E. Miller | W. Palinski | W Palinski | J L Witztum | S Freigang | S Hörkkö | E Miller | S. Hörkkö | J. Witztum | S. Freigang | J. L. Witztum
[1] J. Witztum,et al. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. , 1984, Journal of lipid research.
[2] P. Libby,et al. Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. , 1995, The American journal of pathology.
[3] Y. Hata,et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. , 1996, Journal of lipid research.
[4] P. A. Peterson,et al. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. , 1997, Science.
[5] M. Lopes-Virella,et al. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers , 1993, International journal of clinical & laboratory research.
[6] P. Shah,et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[7] J. Witztum,et al. The oxidation hypothesis of atherosclerosis , 1994, The Lancet.
[8] J L Witztum,et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.
[9] V. Ord,et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[10] S. Ylä-Herttuala,et al. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. , 1990, Arteriosclerosis.
[11] J. Witztum,et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Witztum,et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.
[13] L. Tenkanen,et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. , 1994, Archives of internal medicine.
[14] E M Rubin,et al. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. , 1995, Journal of lipid research.
[15] S. Holm,et al. T lymphocytes inhibit the vascular response to injury. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Hansson,et al. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.
[17] P. Shah,et al. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. , 1997, Journal of the American College of Cardiology.
[18] M. Haberland,et al. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.
[19] E. Emeson,et al. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. , 1993, The American journal of pathology.
[20] J L Witztum,et al. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[21] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[22] D. L. Fletcher,et al. Immunologic basis of transplant-associated arteriosclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Brown,et al. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. , 1990, Archives of pathology & laboratory medicine.
[24] J L Witztum,et al. Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Libby,et al. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. , 1997, The Journal of clinical investigation.
[26] R. Coffman,et al. Heterogeneity of cytokine secretion patterns and functions of helper T cells. , 1989, Advances in immunology.
[27] G. Bellomo,et al. Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM , 1995, Diabetes.
[28] J. Peschon,et al. Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55* , 1996, The Journal of Biological Chemistry.
[29] R. Hammer,et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.
[30] G. Hansson,et al. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. , 1998, The Journal of clinical investigation.
[31] J. D. Smith,et al. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Demer,et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.
[33] P. Edwards,et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.
[34] V. Tertov,et al. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[35] A. Tall,et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.
[36] R. Terkeltaub,et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. , 1996, The Journal of clinical investigation.
[37] A. Gown,et al. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. , 1989, The American journal of pathology.
[38] A. Daugherty,et al. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[39] J. Witztum,et al. A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins. , 1983, The Journal of clinical investigation.
[40] G. Finardi,et al. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. , 1993, Coronary artery disease.
[41] J. Salonen,et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.
[42] D. Collen,et al. beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[43] R. Abraham,et al. Disruption of T cell tolerance by directing a self antigen to macrophage-specific scavenger receptors. , 1997, Journal of immunology.
[44] R. Terkeltaub,et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.
[45] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[46] J. Qiao,et al. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. , 1994, The Journal of clinical investigation.
[47] E. Miller,et al. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[48] D. Steinberg,et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[49] S. Young,et al. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[50] G. Schonfeld,et al. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. , 1995, The Journal of clinical investigation.
[51] S. Basu,et al. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. , 1995, Journal of immunology.
[52] P. Libby,et al. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[53] G. FitzGerald,et al. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. , 1997, Blood.
[54] G. Bellomo,et al. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. , 1994 .
[55] A Daugherty,et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.
[56] M. Olschewski,et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. , 1996, Circulation.
[57] G. Hansson. Cell-mediated immunity in atherosclerosis , 1997, Current opinion in lipidology.
[58] A. Habeeb,et al. Chemical evaluation of conformational differences in native and chemically modified proteins. , 1966, Biochimica et biophysica acta.
[59] S. Constant,et al. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. , 1997, Annual review of immunology.
[60] P. Reaven,et al. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[61] V. Armstrong,et al. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease , 1994, The Lancet.
[62] A. Gown,et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[63] G. Schett,et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. , 1996, Atherosclerosis.
[64] U. de Faire,et al. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[65] G. Jürgens,et al. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[66] J. Witztum,et al. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[67] A. Abbas,et al. Cellular and Molecular Immunology , 1991 .
[68] J L Witztum,et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.
[69] M. Mitchell,et al. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein , 1994, The Lancet.